Avid Bioservices (NASDAQ: CDMO)
Avid Bioservices Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Avid Bioservices Company Info
Avid Bioservices, Inc. engages in the commercial manufacturing. The firm focuses on the biopharmaceutical products derived from mammalian cell culture for culture for biotechnology and pharmaceutical companies. It specializes in clinical and commercial product manufacturing, purification, bulk packaging, stability testing and regulatory submissions and support. The company was founded on June 3, 1981 and is headquartered in Tustin, CA.
News & Analysis
Why Avid Bioservices Stock Was Plummeting This Week
The specialty healthcare services provider had a fiscal fourth quarter to forget.
Why Shares of Avid Bioservices Are Dropping Thursday
The CDMO released fourth-quarter and fiscal 2023 earnings.
Why Avid Bioservices Stock Is Surging Today
The bio-manufacturer's ongoing expansion efforts are a hit with investors.
Why Avid Bioservices Stock Surged 14% Today
The stock will be part of a well-known index.
Why Avid Bioservices Stock Is Soaring Today
The company reported great fiscal 2021 Q2 results.
How Avid Bioservices Beat Wall Street Estimates in Q4
The company still had significant production problems. But it also picked up a lot of new business in Q4.
2 High-Risk, High-Reward Stocks to Add to Your Watch List
These two businesses offer compelling growth potential, but one has yet to deliver on its promise and the other just became more complicated thanks to the coronavirus pandemic.
Here's Why Avid Bioservices Tumbled Today
The drug manufacturer encountered an operational setback, which forced it to slash revenue guidance.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.